Cargando…
Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model
Obesity is a major health problem in the US and globally. Obesity is associated with the risk of cardiovascular disease, type 2 diabetes, cancers, hyperlipidemia, and liver steatosis development. Dehydroepiandrosterone (DHEA) is a dietary supplement used as an anti-obesity supplement. Previously, we...
Autores principales: | Hakkak, Reza, Bell, Andrea, Korourian, Soheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388150/ https://www.ncbi.nlm.nih.gov/pubmed/28335515 http://dx.doi.org/10.3390/scipharm85010013 |
Ejemplares similares
-
Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats
por: Hakkak, Reza, et al.
Publicado: (2018) -
Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
por: Hakkak, Reza, et al.
Publicado: (2022) -
Effects of obesity and 10 weeks metformin treatment on liver steatosis
por: Hakkak, Reza, et al.
Publicado: (2021) -
Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model
por: Hakkak, Reza, et al.
Publicado: (2022) -
Time-dependence of dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEAS), and cortisol in survivors and non-survivors of severe sepsis
por: Marx, C, et al.
Publicado: (2002)